Intersectionality of recipient ancestral group and surrogates of low SES on the donor type
| Associations between recipient ancestral group and low SES surrogates . | ||||
|---|---|---|---|---|
| . | European ancestry∗ (n = 292), % . | Non-European ancestry (n = 133), % . | P value† . | |
| Low SES surrogates | ≥1 | 7/292, 24% | 67/133, 50% | < .001 |
| >2 | 25/292, 9% | 30/133, 23% | < .001 | |
| Neighborhood poverty|| | 14/292, 5% | 7/133, 5% | .80 | |
| Medicaid insurance | 11/292, 4% | 21/133, 16% | < .001 | |
| Financial support | Medical | 29/292, 10% | 34/133, 26% | < .001 |
| Cost-of-living | 47/292, 16% | 40/133, 30% | < .001 | |
| Mean fold difference in funds/patient supported | Reference | 140% | — | |
| Associations between recipient ancestral group and low SES surrogates . | ||||
|---|---|---|---|---|
| . | European ancestry∗ (n = 292), % . | Non-European ancestry (n = 133), % . | P value† . | |
| Low SES surrogates | ≥1 | 7/292, 24% | 67/133, 50% | < .001 |
| >2 | 25/292, 9% | 30/133, 23% | < .001 | |
| Neighborhood poverty|| | 14/292, 5% | 7/133, 5% | .80 | |
| Medicaid insurance | 11/292, 4% | 21/133, 16% | < .001 | |
| Financial support | Medical | 29/292, 10% | 34/133, 26% | < .001 |
| Cost-of-living | 47/292, 16% | 40/133, 30% | < .001 | |
| Mean fold difference in funds/patient supported | Reference | 140% | — | |
| Associations between recipient ancestral group, low SES surrogates, and donor type . | |||||
|---|---|---|---|---|---|
| . | European ancestry∗ (n = 292), % . | Non-European ancestry . | P value† . | ||
| HLA-matched (n = 57), % . | HLA-disparate (n = 76), %‡,§ . | ||||
| Low SES surrogates | ≥1 | 71/292, 24% | 24/57, 42% | 43/76, 57% | < .001 |
| ≥2 | 25/292, 9% | 9/57, 16% | 21/76, 28% | < .001 | |
| Neighborhood poverty|| | 14/292, 5% | 2/57, 4% | 5/76, 7% | .80 | |
| Medicaid insurance | 11/292, 4% | 8/57, 14% | 13/76, 17% | < .001 | |
| Financial support | Medical | 29/292, 10% | 12/57, 21% | 22/76, 29% | < .001 |
| Cost-of-living | 47/292, 16% | 13/57, 23% | 27/76, 36% | < .001 | |
| Mean fold difference in funds/patient supported | Reference | 117% | 150% | — | |
| Associations between recipient ancestral group, low SES surrogates, and donor type . | |||||
|---|---|---|---|---|---|
| . | European ancestry∗ (n = 292), % . | Non-European ancestry . | P value† . | ||
| HLA-matched (n = 57), % . | HLA-disparate (n = 76), %‡,§ . | ||||
| Low SES surrogates | ≥1 | 71/292, 24% | 24/57, 42% | 43/76, 57% | < .001 |
| ≥2 | 25/292, 9% | 9/57, 16% | 21/76, 28% | < .001 | |
| Neighborhood poverty|| | 14/292, 5% | 2/57, 4% | 5/76, 7% | .80 | |
| Medicaid insurance | 11/292, 4% | 8/57, 14% | 13/76, 17% | < .001 | |
| Financial support | Medical | 29/292, 10% | 12/57, 21% | 22/76, 29% | < .001 |
| Cost-of-living | 47/292, 16% | 13/57, 23% | 27/76, 36% | < .001 | |
| Mean fold difference in funds/patient supported | Reference | 117% | 150% | — | |
Because very few European HLA-disparate graft recipients had low SES, all European recipients' data were combined.
P values were generated via Pearson χ2 tests or Fisher exact tests. Significant P values are shown in bold.
Includes 19 non-Black Hispanic, 36 African, 20 Asian, and 1 mixed non-European ancestry patients.
25 patients received CB, 30 haploidentical, and 21 mmURD grafts.
ADI national percentile ≥60.